nCoV Map

WHO contact tracing and quarantine in the context of the Omicron SARS-CoV-2 Variant
17 February, 2022
Look at risks and benefits first...
COVID-19
Study reports on risk of mental health disorders associated with COVID-19
United States // 17 February, 2022
Increased risk of mental health disorders following acute phase of COVID-19...
COVID-19
Vaccination during pregnancy protects infants
United States // 16 February, 2022
Up to 61% protection against hospitalisation…
COVID-19
Vaccine Update – Vaccinations for children aged 5 to 11 years underway
Malaysia // 16 February, 2022
Vaccinations for children aged 5 to 11 years began on 3 February...
COVID-19
Vaccine Update – 600,000 doses of vaccine delivered
Hong Kong (China SAR) // 14 February, 2022
Authorities have announced that the eligible age for the Sinovac vaccine will be lowered to three years old...
COVID-19
COVID-19 vaccination status "up-to-date" rather than "fully vaccinated"
Australia // 12 February, 2022
Authorities now use the term "up-to-date" for public health management....
COVID-19
Oral antiviral Paxlovid approved to treat COVID-19
China // 12 February, 2022
The conditional approval is for use in adults who are at high risk of progressing to severe disease....
COVID-19
ECDC updates report on face mask use for Omicron
12 February, 2022
Respirators are probably more effective than face masks but fit and seal are importmant....
COVID-19
FDA authorises bebtelovimab
United States // 11 February, 2022
Drug shown to be active against the Omicron variant…
COVID-19
US postpones vote on vaccine for youngest children
United States // 11 February, 2022
Three dose series to be evaluated…
COVID-19
CDC study finds booster immunity wanes
United States // 11 February, 2022
Reduction in effectiveness noted as early as 4 months...
COVID-19
Tocilizumab receives WHO prequalification
11 February, 2022
First monoclonal antibody treatment to receive prequalification…
COVID-19
Novavax authorised
South Korea // 11 February, 2022
First doses on order…
COVID-19
ECDC urges caution with antibody tests
10 February, 2022
New technical report for clinicians published…
COVID-19
Study looks at risk of developing new medical conditions after acute COVID-19
United States // 10 February, 2022
Higher risk not limited to people who required hospital treatment for COVID-19...
COVID-19
Nasal spray launched to treat COVID-19
India // 09 February, 2022
Glenmark in partnership with SaNOtize launched (PDF) a nasal spray to treat adult COVID-19...
COVID-19
Omicron may last longer on surfaces than other variants
08 February, 2022
Variants of concerns assessed for survival on skin and plastic.
COVID-19
Long-term cardiovascular outcomes of COVID-19
United States // 07 February, 2022
Increased risk not limited to individuals who required hospital treatment...
COVID-19
Moderna gains full regulatory approval
United States // 05 February, 2022
Second vaccine to do so…
COVID-19
Seroprevalence studies show true infections with COVID-19 globally far exceed those reported
03 February, 2022
True case numbers globally far exceed those reported...
COVID-19

Quick Links

nCoV Map

LATEST NEWS (PREMIUM ACCESS)